Abstract

To evaluate the diagnostic value of intravoxel incoherent motion (IVIM) and diffusional kurtosis imaging (DKI) parameters in nasal or sinonasal squamous cell carcinoma (SCC) patients to determine local control/failure. Twenty-eight patients were evaluated. MR acquisition used single-shot spin-echo EPI with 12 b-values. Quantitative parameters (mean value, 25th, 50th and 75th percentiles) of IVIM (perfusion fraction f, pseudo-diffusion coefficient D*, and true-diffusion coefficient D), DKI (kurtosis value K, kurtosis corrected diffusion coefficient Dk) and apparent diffusion coefficient (ADC) were calculated. Parameter values at both the pretreatment and early-treatment period, and the percentage change between these two periods were obtained. Multivariate logistic regression analysis: the percentage changes of D (mean, 25th, 50th, 75th), K (mean, 50th, 75th), Dk (mean, 25th, 50th), and ADC (mean, 25th, 50th) were predictors of local control. ROC curve analysis: the parameter with the highest accuracy = the percentage change of D value with the histogram 25th percentile (0.93 diagnostic accuracy). Multivariate Cox regression analyses: the percentage changes of D (mean, 25th, 50th), K (mean, 50th, 75th), Dk (mean, 25th, 50th) and ADC (mean, 25th, 50th) are predictors. IVIM and DKI parameters, especially the D-value's histogram 25th percentile, are useful for predicting local control. • Noninvasive assessment of treatment outcome in SCC patients was achieved using IVIM/DKI. • Several IVIM and DKI parameters can predict the local control. • Especially, the D-value's histogram 25th percentile has high diagnostic accuracy.

Highlights

  • Surgical resection, chemotherapy, radiotherapy, and their combinations are common treatments for head and neck squamous cell carcinoma (SCC), including nasal or sinonasal cavity SCC [1]

  • The Response Evaluation Criteria in Solid Tumors (RECIST) criteria provide a standard method [4], but it was reported that tumor size information is not very reliable for predicting treatment outcomes [5]

  • From September 2010 to June 2014, 31 consecutive patients who were referred to our hospital to undergo a super-selective arterial infusion of cisplatin with concomitant radiotherapy under a diagnosis of nasal or sinonasal cancer were prospectively enrolled with the following inclusion criteria: (1)

Read more

Summary

Introduction

Chemotherapy, radiotherapy, and their combinations are common treatments for head and neck squamous cell carcinoma (SCC), including nasal or sinonasal cavity SCC [1]. Super-selective arterial infusions of cisplatin with concomitant radiotherapy, in particular, have become popular for SCC because of its higher local control rate in advanced cases of nasal or sinonasal SCC [2, 3]. For such a nonsurgical therapy, it would be helpful to be able to predict — either before treatment or during the early treatment period — the treatment results of patients who may fail to respond to treatment at the primary site; doing so could optimize patient management. The apparent diffusion coefficient (ADC) obtained by diffusion-weighted imaging (DWI)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call